Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2

The mechanisms that govern the transdifferentiation of lung adenocarcinomas (ADC) to squamous cell carcinoma (SCC) are not fully understood. Here, the authors show that EZH2 loss exacerbates the transdifferentiation of ADCs to SCCs as a result of chromatin changes that lead to expression of squamous...

Full description

Bibliographic Details
Main Authors: Haikuo Zhang, Christine Fillmore Brainson, Shohei Koyama, Amanda J. Redig, Ting Chen, Shuai Li, Manav Gupta, Carolina Garcia-de-Alba, Margherita Paschini, Grit S. Herter-Sprie, Gang Lu, Xin Zhang, Bryan P. Marsh, Stephanie J. Tuminello, Chunxiao Xu, Zhao Chen, Xiaoen Wang, Esra A. Akbay, Mei Zheng, Sangeetha Palakurthi, Lynette M. Sholl, Anil K. Rustgi, David J. Kwiatkowski, J Alan Diehl, Adam J. Bass, Norman E. Sharpless, Glenn Dranoff, Peter S. Hammerman, Hongbin Ji, Nabeel Bardeesy, Dieter Saur, Hideo Watanabe, Carla F. Kim, Kwok-Kin Wong
Format: Article
Language:English
Published: Nature Portfolio 2017-04-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/ncomms14922
_version_ 1828972953739460608
author Haikuo Zhang
Christine Fillmore Brainson
Shohei Koyama
Amanda J. Redig
Ting Chen
Shuai Li
Manav Gupta
Carolina Garcia-de-Alba
Margherita Paschini
Grit S. Herter-Sprie
Gang Lu
Xin Zhang
Bryan P. Marsh
Stephanie J. Tuminello
Chunxiao Xu
Zhao Chen
Xiaoen Wang
Esra A. Akbay
Mei Zheng
Sangeetha Palakurthi
Lynette M. Sholl
Anil K. Rustgi
David J. Kwiatkowski
J Alan Diehl
Adam J. Bass
Norman E. Sharpless
Glenn Dranoff
Peter S. Hammerman
Hongbin Ji
Nabeel Bardeesy
Dieter Saur
Hideo Watanabe
Carla F. Kim
Kwok-Kin Wong
author_facet Haikuo Zhang
Christine Fillmore Brainson
Shohei Koyama
Amanda J. Redig
Ting Chen
Shuai Li
Manav Gupta
Carolina Garcia-de-Alba
Margherita Paschini
Grit S. Herter-Sprie
Gang Lu
Xin Zhang
Bryan P. Marsh
Stephanie J. Tuminello
Chunxiao Xu
Zhao Chen
Xiaoen Wang
Esra A. Akbay
Mei Zheng
Sangeetha Palakurthi
Lynette M. Sholl
Anil K. Rustgi
David J. Kwiatkowski
J Alan Diehl
Adam J. Bass
Norman E. Sharpless
Glenn Dranoff
Peter S. Hammerman
Hongbin Ji
Nabeel Bardeesy
Dieter Saur
Hideo Watanabe
Carla F. Kim
Kwok-Kin Wong
author_sort Haikuo Zhang
collection DOAJ
description The mechanisms that govern the transdifferentiation of lung adenocarcinomas (ADC) to squamous cell carcinoma (SCC) are not fully understood. Here, the authors show that EZH2 loss exacerbates the transdifferentiation of ADCs to SCCs as a result of chromatin changes that lead to expression of squamous differentiation genes.
first_indexed 2024-12-14T13:37:33Z
format Article
id doaj.art-0ce62822a53e4bae828250fb78660d57
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-12-14T13:37:33Z
publishDate 2017-04-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-0ce62822a53e4bae828250fb78660d572022-12-21T22:59:32ZengNature PortfolioNature Communications2041-17232017-04-018111510.1038/ncomms14922Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2Haikuo Zhang0Christine Fillmore Brainson1Shohei Koyama2Amanda J. Redig3Ting Chen4Shuai Li5Manav Gupta6Carolina Garcia-de-Alba7Margherita Paschini8Grit S. Herter-Sprie9Gang Lu10Xin Zhang11Bryan P. Marsh12Stephanie J. Tuminello13Chunxiao Xu14Zhao Chen15Xiaoen Wang16Esra A. Akbay17Mei Zheng18Sangeetha Palakurthi19Lynette M. Sholl20Anil K. Rustgi21David J. Kwiatkowski22J Alan Diehl23Adam J. Bass24Norman E. Sharpless25Glenn Dranoff26Peter S. Hammerman27Hongbin Ji28Nabeel Bardeesy29Dieter Saur30Hideo Watanabe31Carla F. Kim32Kwok-Kin Wong33Department of Medical Oncology, Dana-Farber Cancer InstituteStem Cell Program and Division of Hematology/Oncology, Boston Children’s Hospital BostonDepartment of Medical Oncology, Dana-Farber Cancer InstituteDepartment of Medical Oncology, Dana-Farber Cancer InstituteDepartment of Medical Oncology, Dana-Farber Cancer InstituteDepartment of Medical Oncology, Dana-Farber Cancer InstituteStem Cell Program and Division of Hematology/Oncology, Boston Children’s Hospital BostonStem Cell Program and Division of Hematology/Oncology, Boston Children’s Hospital BostonStem Cell Program and Division of Hematology/Oncology, Boston Children’s Hospital BostonDepartment of Medical Oncology, Dana-Farber Cancer InstituteDepartment of Medical Oncology, Dana-Farber Cancer InstituteDepartment of Medical Oncology, Dana-Farber Cancer InstituteStem Cell Program and Division of Hematology/Oncology, Boston Children’s Hospital BostonDepartment of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine; Tisch Cancer Institute, Icahn School of Medicine at Mount SinaiDepartment of Medical Oncology, Dana-Farber Cancer InstituteDepartment of Medical Oncology, Dana-Farber Cancer InstituteDepartment of Medical Oncology, Dana-Farber Cancer InstituteDepartment of Medical Oncology, Dana-Farber Cancer InstituteDepartment of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolBelfer Institute for Applied Cancer Science, Dana-Farber Cancer InstituteDepartment of Medical Oncology, Dana-Farber Cancer InstituteDivision of Gastroenterology, Department of Medicine and Genetics, University of Pennsylvania Perelman School of Medicine, Abramson Cancer CenterDepartment of Medical Oncology, Dana-Farber Cancer InstituteDepartment of Biochemical and Molecular Biology, Medical University of South CarolinaDepartment of Medical Oncology, Dana-Farber Cancer InstituteUniversity of North Carolina Lineberger Comprehensive Cancer Center, UNC School of MedicineDepartment of Medical Oncology, Dana-Farber Cancer InstituteDepartment of Medical Oncology, Dana-Farber Cancer InstituteKey Laboratory of Systems Biology, CAS Center for Excellence in Molecular Cell Science, Innovation Center for Cell Signaling Network, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of SciencesCancer Center, Massachusetts General HospitalDepartment of Internal Medicine II, Klinikum rechts der Isar, Technische Universität MünchenBelfer Institute for Applied Cancer Science, Dana-Farber Cancer InstituteStem Cell Program and Division of Hematology/Oncology, Boston Children’s Hospital BostonDepartment of Medical Oncology, Dana-Farber Cancer InstituteThe mechanisms that govern the transdifferentiation of lung adenocarcinomas (ADC) to squamous cell carcinoma (SCC) are not fully understood. Here, the authors show that EZH2 loss exacerbates the transdifferentiation of ADCs to SCCs as a result of chromatin changes that lead to expression of squamous differentiation genes.https://doi.org/10.1038/ncomms14922
spellingShingle Haikuo Zhang
Christine Fillmore Brainson
Shohei Koyama
Amanda J. Redig
Ting Chen
Shuai Li
Manav Gupta
Carolina Garcia-de-Alba
Margherita Paschini
Grit S. Herter-Sprie
Gang Lu
Xin Zhang
Bryan P. Marsh
Stephanie J. Tuminello
Chunxiao Xu
Zhao Chen
Xiaoen Wang
Esra A. Akbay
Mei Zheng
Sangeetha Palakurthi
Lynette M. Sholl
Anil K. Rustgi
David J. Kwiatkowski
J Alan Diehl
Adam J. Bass
Norman E. Sharpless
Glenn Dranoff
Peter S. Hammerman
Hongbin Ji
Nabeel Bardeesy
Dieter Saur
Hideo Watanabe
Carla F. Kim
Kwok-Kin Wong
Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
Nature Communications
title Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
title_full Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
title_fullStr Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
title_full_unstemmed Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
title_short Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2
title_sort lkb1 inactivation drives lung cancer lineage switching governed by polycomb repressive complex 2
url https://doi.org/10.1038/ncomms14922
work_keys_str_mv AT haikuozhang lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT christinefillmorebrainson lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT shoheikoyama lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT amandajredig lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT tingchen lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT shuaili lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT manavgupta lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT carolinagarciadealba lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT margheritapaschini lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT gritshertersprie lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT ganglu lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT xinzhang lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT bryanpmarsh lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT stephaniejtuminello lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT chunxiaoxu lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT zhaochen lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT xiaoenwang lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT esraaakbay lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT meizheng lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT sangeethapalakurthi lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT lynettemsholl lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT anilkrustgi lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT davidjkwiatkowski lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT jalandiehl lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT adamjbass lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT normanesharpless lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT glenndranoff lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT petershammerman lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT hongbinji lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT nabeelbardeesy lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT dietersaur lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT hideowatanabe lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT carlafkim lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2
AT kwokkinwong lkb1inactivationdriveslungcancerlineageswitchinggovernedbypolycombrepressivecomplex2